Safety of sublingual immunotherapy with monomeric all_ergoid in adults: multicenter post‐marketing surveillance study
- 1 October 2001
- Vol. 56 (10) , 989-992
- https://doi.org/10.1034/j.1398-9995.2001.00181.x
Abstract
Background: Sublingual immunotherapy (SLIT) appears to be acceptably safe in clinical trials, but post‐marketing data are needed to provide essential information. This study specificall_y evaluated ...Keywords
This publication has 6 references indexed in Scilit:
- Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteersClinical and Experimental Allergy, 2001
- Sublingual IT in OASAllergy, 2000
- Safety of Sublingual-Swallow Immunotherapy in Children and AdultsInternational Archives of Allergy and Immunology, 2000
- Post‐marketing surveillance study on the safety of sublingual immunotherapy in pediatric patientsAllergy, 1999
- Sublingual immunotherapyJournal of Allergy and Clinical Immunology, 1999
- Local immunotherapyAllergy, 1998